PortfoliosLab logoPortfoliosLab logo
CC vs. IOSP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CC vs. IOSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Chemours Company (CC) and Innospec Inc. (IOSP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CC achieves a 93.43% return, which is significantly higher than IOSP's 6.54% return. Over the past 10 years, CC has outperformed IOSP with an annualized return of 13.99%, while IOSP has yielded a comparatively lower 6.61% annualized return.


CC

1D
-2.75%
1M
-16.64%
YTD
93.43%
6M
75.97%
1Y
132.66%
3Y*
-9.21%
5Y*
-6.37%
10Y*
13.99%

IOSP

1D
-1.29%
1M
6.63%
YTD
6.54%
6M
8.95%
1Y
-4.79%
3Y*
-5.16%
5Y*
-3.08%
10Y*
6.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CC vs. IOSP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CC
The Chemours Company
93.43%-27.57%-44.01%6.53%-5.99%39.85%45.61%-32.54%-42.45%127.24%
IOSP
Innospec Inc.
6.54%-28.94%-9.57%21.46%15.25%0.77%-11.00%69.43%-11.48%4.30%

Correlation

The correlation between CC and IOSP is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.53

Correlation (3Y)
Calculated over the trailing 3-year period

0.51

Correlation (5Y)
Calculated over the trailing 5-year period

0.55

Correlation (10Y)
Calculated over the trailing 10-year period

0.51

Correlation (All Time)
Calculated using the full available price history since Jul 2, 2015

0.48

The correlation between CC and IOSP has been stable across timeframes, ranging from 0.48 to 0.55 - a consistent structural relationship.

Fundamentals

EPS

CC:

-$3.65

IOSP:

$4.58

PS Ratio

CC:

0.44

IOSP:

1.12

Total Revenue (TTM)

CC:

$5.82B

IOSP:

$1.79B

Gross Profit (TTM)

CC:

$878.00M

IOSP:

$490.80M

EBITDA (TTM)

CC:

$66.00M

IOSP:

$162.50M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CC vs. IOSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CC
CC Risk / Return Rank: 8484
Overall Rank
CC Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
CC Sortino Ratio Rank: 8282
Sortino Ratio Rank
CC Omega Ratio Rank: 8181
Omega Ratio Rank
CC Calmar Ratio Rank: 8484
Calmar Ratio Rank
CC Martin Ratio Rank: 8383
Martin Ratio Rank

IOSP
IOSP Risk / Return Rank: 3131
Overall Rank
IOSP Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
IOSP Sortino Ratio Rank: 2727
Sortino Ratio Rank
IOSP Omega Ratio Rank: 2727
Omega Ratio Rank
IOSP Calmar Ratio Rank: 3434
Calmar Ratio Rank
IOSP Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CC vs. IOSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Chemours Company (CC) and Innospec Inc. (IOSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CCIOSPDifference
Sharpe ratioReturn per unit of total volatility

+2.29

Sortino ratioReturn per unit of downside risk

+2.65

Omega ratioGain probability vs. loss probability

1.32

0.99

+0.34

Calmar ratioReturn relative to maximum drawdown

3.35

-0.19

+3.54

Martin ratioReturn relative to average drawdown

7.97

-0.40

+8.37

CC vs. IOSP - Sharpe Ratio Comparison

The current CC Sharpe Ratio is 2.09, which is higher than the IOSP Sharpe Ratio of -0.20. The chart below compares the historical Sharpe Ratios of CC and IOSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CCIOSPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.09

-0.20

+2.29

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.11

-0.12

0.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.24

0.21

+0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

0.11

0.16

-0.05

Drawdowns

CC vs. IOSP - Drawdown Comparison

The maximum CC drawdown since its inception was -86.15%, smaller than the maximum IOSP drawdown of -91.17%. Use the drawdown chart below to compare losses from any high point for CC and IOSP.


Loading charts...

Drawdown Indicators


CCIOSPDifference

Max Drawdown

Largest peak-to-trough decline

-86.15%

-91.17%

+5.02%

Max Drawdown (1Y)

Largest decline over 1 year

-39.79%

-25.48%

-14.31%

Max Drawdown (3Y)

Largest decline over 3 years

-73.60%

-48.42%

-25.18%

Max Drawdown (5Y)

Largest decline over 5 years

-76.42%

-48.42%

-28.00%

Max Drawdown (10Y)

Largest decline over 10 years

-86.15%

-48.42%

-37.73%

Current Drawdown

Current decline from peak

-45.63%

-36.16%

-9.47%

Average Drawdown

Average peak-to-trough decline

-40.96%

-28.68%

-12.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.71%

12.14%

+4.57%

Volatility

CC vs. IOSP - Volatility Comparison

The Chemours Company (CC) has a higher volatility of 23.87% compared to Innospec Inc. (IOSP) at 7.93%. This indicates that CC's price experiences larger fluctuations and is considered to be riskier than IOSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CCIOSPDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.87%

7.93%

+15.94%

Volatility (6M)

Calculated over the trailing 6-month period

47.42%

17.24%

+30.18%

Volatility (1Y)

Calculated over the trailing 1-year period

63.94%

24.24%

+39.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

55.65%

26.65%

+29.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

57.45%

31.33%

+26.12%

Dividends

CC vs. IOSP - Dividend Comparison

CC's dividend yield for the trailing twelve months is around 1.55%, less than IOSP's 2.22% yield.


PositionTTM20252024202320222021202020192018201720162015
CC
The Chemours Company
1.55%4.35%5.92%3.17%3.27%2.98%4.03%5.53%2.98%0.24%0.54%10.82%
IOSP
Innospec Inc.
2.22%2.23%1.41%1.14%1.24%1.28%1.15%0.99%1.44%1.09%0.98%1.12%

Financials

CC vs. IOSP - Financials Comparison

This section allows you to compare key financial metrics between The Chemours Company and Innospec Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00B20222023202420252026
1.38B
453.20M
(CC) Total Revenue
(IOSP) Total Revenue
Values in USD except per share items

CC vs. IOSP - Profitability Comparison

The chart below illustrates the profitability comparison between The Chemours Company and Innospec Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%15.0%20.0%25.0%30.0%20222023202420252026
15.4%
27.3%
Portfolio components
CC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Chemours Company reported a gross profit of 212.00M and revenue of 1.38B. Therefore, the gross margin over that period was 15.4%.

IOSP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Innospec Inc. reported a gross profit of 123.50M and revenue of 453.20M. Therefore, the gross margin over that period was 27.3%.

CC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Chemours Company reported an operating income of 39.00M and revenue of 1.38B, resulting in an operating margin of 2.8%.

IOSP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Innospec Inc. reported an operating income of 36.50M and revenue of 453.20M, resulting in an operating margin of 8.1%.

CC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Chemours Company reported a net income of -29.00M and revenue of 1.38B, resulting in a net margin of -2.1%.

IOSP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Innospec Inc. reported a net income of 30.40M and revenue of 453.20M, resulting in a net margin of 6.7%.


Frequently Asked Questions


CC and IOSP have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CC has higher volatility (23.87%) compared to IOSP (7.93%). In terms of maximum drawdown, CC dropped -86.15% vs IOSP's -91.17%.

CC currently has the higher Sharpe Ratio (2.09 vs -0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CC and IOSP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer